Member Login
  1. Stocks
    2. /
  2. Neighbourly Pharmacy (TSX: NBLY)
    3. /

TSX:NBLY (Neighbourly Pharmacy)

About NBLY

Neighbourly Pharmacy, Inc. operates a network of community pharmacies. It offers pharmacy and medical distribution services. The company was founded by Brian Dawson on March 20, 2015 and is headquartered in Toronto, Canada.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Neighbourly Pharmacy (TSX: NBLY) Latest News

    Money growing in soil , Business success concept.
    Investing

    3 Incredible Canadian Growth Stocks That Could Turn $10,000 Into $50,000

    | Daniel Da Costa

    These three Canadian growth stocks have incredible operations and significant long-term potential, making them some of the best to buy…

    Read more »

    A bull outlined against a field
    Investing

    Turbocharge Your Portfolio for a Bull Market With 2 TSX Small Caps

    | Aditya Raghunath

    Small-cap TSX stocks such as Well Health offer investors an opportunity to derive outsized gains in the upcoming decade.

    Read more »

    Man holding magnifying glass over a document
    Investing

    3 Undervalued TSX Gems to Watch in March 2023

    | Aditya Raghunath

    Value investors looking to beat the TSX can consider buying shares of Shawcor, and two other stocks, right now. Let's…

    Read more »

    A doctor takes a patient's blood pressure in a clinical office.
    Dividend Stocks

    3 Healthcare Stocks With Long Growth Runways

    | Christopher Liew, CFA

    Three healthcare stocks with long growth runways could lift the sector to greater heights in 2023 and beyond.

    Read more »

    clock time
    Investing

    Want to Be a Millionaire? Invest $75,000 Into These 4 Phenomenal Stocks and Wait 20 Years

    | Daniel Da Costa

    These four stocks can help make you a millionaire, because they each offer compelling value today and have significant growth…

    Read more »

    potted green plant grows up in arrow shape
    Investing

    Here’s My Top Growth Stock to Buy Right Now

    | Daniel Da Costa

    Although investors have several high-quality choices of stocks to buy in this environment, here's my top growth stock to buy…

    Read more »

    grow dividends
    Investing

    4 Cheap Canadian Stocks That Can Still Grow Their Earnings Next Year

    | Daniel Da Costa

    While economic growth is expected to slow significantly in 2023, these four Canadian stocks are cheap and have significant growth…

    Read more »

    Glass piggy bank
    Investing

    5 Canadian Stocks Expected to Grow Sales by Over 18% in 2023

    | Daniel Da Costa

    Although many expect economic growth to stall in 2023, these five Canadian stocks are forecast to continue growing rapidly.

    Read more »

    Business success with growing, rising charts and businessman in background
    Investing

    3 Growth-by-Acquisition Stocks to Buy and Hold for Years

    | Daniel Da Costa

    These three growth stocks each have exceptional businesses, making them some of the best to buy and hold for the…

    Read more »

    A close up image of Canadian $20 Dollar bills
    Investing

    3 Top Stocks You Can Still Buy for Under $20 a Share

    | Daniel Da Costa

    While these three Canadian stocks trade undervalued and below $20 a share, they are easily some of the top investments…

    Read more »

    data analytics, chart and graph icons with female hands typing on laptop in background
    Dividend Stocks

    Smart Buys: 2 Low-Profile Value Stocks With Strong Upside

    | Christopher Liew, CFA

    Two low-profile value stocks with strong upside are smart buys if you’re looking for investments outside the energy sector.

    Read more »

    supplements vitamins pills
    Investing

    Neighbourly Pharmacy (TSX:NBLY): Top Healthcare Stock for Q3 2022

    | Christopher Liew, CFA

    A healthcare stock with defensive properties and excellent growth prospects should be an interesting buy in Q3 2022.

    Read more »